From 15–18 September 2025, the 4th Antibody Technologies and Therapeutics Conference took place at the Prato campus of Monash University in Italy. Since 2015, this event has brought together a select group of leading scientists from academia and industry to exchange on antibody engineering, structure and dynamics, and emerging therapeutic targets in inflammation, infection, oncology, and metabolic disease.
ABCardionostics coordinator Dr. Gisèle Clofent-Sanchez contributed to the programme with a presentation entitled:
“Fully human antibodies for theranostic applications in atherosclerosis.”
It was a real pleasure to see the interest in our project and to exchange with such an engaged community of researchers and innovators in the antibody field.
We warmly thank the organisers – Karen Alt, Remy Robert, Christoph Hagemeyer and Mark Sleeman – for hosting such an inspiring conference.
